Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

RAPT Therapeutics Q2 EPS $(0.71) Beats $(0.72) Estimate

Author: Benzinga Newsdesk | August 08, 2024 08:27am
RAPT Therapeutics (NASDAQ:RAPT) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.72) by 1.39 percent. This is a 7.58 percent decrease over losses of $(0.66) per share from the same period last year.

Posted In: RAPT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist